Contact us at:
Prof. Dr. Akmal Nabil Ahmad El-Mazny, MD, FICS; Professor of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Egypt. He was graduated from Cairo University, Egypt. He pursued his masters and MD in the field of Obstetrics and Gynecology. His sub-specialties include assisted reproduction and gynecologic endoscopy. He contributed over 65 international publications to the world of scientific community. He is also a peer reviewer and associate editor for many renowned journals like F&S, EJOGRB, UOG, ARCH, JGO, MEFS etc.
Obstetrics and Gynecology, Infertility and assisted reproduction, Gynecologic endoscopy (laparoscopy/hysteroscopy), obstetric and Gynecologic ultrasound
The immune function of anti-aging biophysics, RNAi-mediated treatment, Chinese herbal medicine cancer treatment, Nanotechnology in cancer treatment, and stem cell therapy in translational medicine
Biotechnology and Genetic Engineering
He received his MBBS and Ph.D. from Institute of Medical Science, The University of Tokyo in 1994. He was research training as a graduate student in Virology Division (late professor Hiroshi Shibuta), at Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo Japan until 1991. He investigated and elucidated the molecular mechanism of human immunodeficiency virus (HIV) type 1 particle formation for development of New AIDS vaccination system using recombinant vaccinia virus. He was research training as a resident staff in Virology Division (Division Chief, Dr. Kunitada Shimotohno), at National Cancer Center, Tokyo Japan for 3 years until 1994 and joined Whitehead Institute for Biomedical research (W.I.B.R.) at Massachusetts Institute of Technology (M.I.T.) that year. He did postdoctoral training in the laboratory of Dr. Richard A. Young (W.I.B.R. at M.I.T., Membership of National Academy of Sciences), and also was a research member of Project of New England AIDS vaccine development (Project Leader: Dr. David Baltimore, Nobel Laureate 1975, Honorary president, California Institute of Technology). After postdoctoral training, he got faculty position Lecture, Massachusetts General Hospital (M.G.H.) at Harvard Medical School (H.M.S.) in 1997. He has been studying the sarcoma genesis of human uterine leiomyosarcomas with proteasome subunit LMP2-deficient mice, under the research co-operation of Dr. Susumu Tonegawa (Nobel Laureate 1987, the Picower Institute for Learning and Memory at M.I.T.). He identifies diagnostic biomarkers, LMP2, Cyclin B1 and Cyclin E, which distinguish human malignant tumour uterine leiomyosarcoma from other human uterine mesenchymal tumours including benign tumour uterine leiomyoma. He also focus physiological significance of NF-Bp50 in survival of central nerves cells.
molecular approach of tumorigenesis of gynecological tumors including human uterine mesenchymal tumours, especially uterine leiomyosarcoma, ovarian tumor, especially high-grade serous ovarian carcinoma and other research filed; neuronal cell survival of central nerves system
Biology and Biotechnology
a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com.
Best viewed in
| Above IE 9.0 version | Privacy Policy
